MACROmol Overview

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

MACROmol General Information

Description

Developer of a polymeric platform designed to treat tuberculosis. The company's polymeric platform offers a multi-medicine system for nanomedicine innovation to maximize the clinical impact of therapeutics, enabling patients to have fewer drug regimens with improved results.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 16 Jubilee Parkway Jubilee Business Park
  • Derby DE21 4BJ
  • England, United Kingdom
Primary Industry
Pharmaceuticals
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Life Sciences
Corporate Office
  • 16 Jubilee Parkway Jubilee Business Park
  • Derby DE21 4BJ
  • England, United Kingdom

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MACROmol Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 01-Apr-2015 Completed Startup
To view MACROmol’s complete valuation and funding history, request access »

Ready to get started?

Request a free trial

MACROmol FAQs

  • Where is MACROmol headquartered?

    MACROmol is headquartered in Derby, United Kingdom.

  • What industry is MACROmol in?

    MACROmol’s primary industry is Pharmaceuticals.

  • Is MACROmol a private or public company?

    MACROmol is a Private company.

  • What is MACROmol’s current revenue?

    The current revenue for MACROmol is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »